A Real World Multi Centre Study Of CPX-351 Reveals No Difference In Overall Survival When Compared With FLAG-IDA And 3 + 7 In High-Risk AML

Ibrahim Al Nabhani

A Real World Multi Centre Study Of CPX-351 Reveals No Difference In Overall Survival When Compared With FLAG-IDA And 3 + 7 In High-Risk AML

Haematology

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	HemaSphere
Publication status	Published - Dec 2022

Cite this

@article{5ddd635ac29b4603a26166c324824c3b,

title = "A Real World Multi Centre Study Of CPX-351 Reveals No Difference In Overall Survival When Compared With FLAG-IDA And 3 + 7 In High-Risk AML",

author = "{Al Nabhani}, Ibrahim",

year = "2022",

month = dec,

language = "English",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wolters Kluwer Health",

}